• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE Back to Search Results
Model Number 787426
Medical Device Problem Code Material Fragmentation (1261)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/07/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event or Problem Description
It was reported that when opening the package, the two pigtail rings of the ureteral stent were found to be ruptured.
 
Additional Manufacturer Narrative
The reported event is confirmed, cause unknown.A photo sample was submitted which showed the stent broken into two pieces.Visual evaluation noted the sample was separated on the body of the stent, the separation appeared to be cut as the material did not appear to be stretched or discolored.The suture was threaded through the entire body of the stent and the portholes.Although a specific root cause cannot be determined, based on the risk document a potential root cause for this event could be, "inappropriate package design".No manufacturing issues or non-conformances were noted during review of the dhr that could have caused or contributed to the reported event.The instructions for use were found adequate and states the following: the inlay optima ureteral stent instructions for use, baw7659454 revision 0, was reviewed and found to be adequate as it states: "avoid improper handling of stent such as bending, kinking, tearing, etc.Misuse could damage the overall integrity of the stent." "care should be exercised when removing the stent from the inner polybag to eliminate tearing or fragmentation." the actual/suspected device was inspected.
 
Event or Problem Description
It was reported that when opening the package, the two pigtail rings of the ureteral stent were found to be ruptured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE
Common Device Name
GUIDEWIRE
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key15447360
Report Number1018233-2022-07254
Device Sequence Number12638089
Product Code FAD
UDI-Device Identifier10801741015363
UDI-Public(01)10801741015363
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K043193
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/28/2026
Device Model Number787426
Device Catalogue Number787426
Device Lot NumberNGGN1705
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/07/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/07/2022
Supplement Date Received by Manufacturer02/11/2023
Initial Report FDA Received Date09/19/2022
Supplement Report FDA Received Date02/14/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/03/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-